Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction

Refractory Status Epilepticus Treatment (RESET): Quality and Efficacy of Coma Induction

This study is to investigate the effects of different treatment characteristics regarding the use of intravenous anesthetic drugs (IVADs) as a rescue treatment for refractory Status epilepticus (RSE) on course and outcome. A retrospective data extraction from the digital medical records, the electroencephalographic and microbiologic database of all consecutive adult patients with Status epilepticus (SE) admitted to the University Hospital Basel is undertaken.

Inclusion Criteria:

• diagnosed SE between 2005 and 2019 who have been treated at intensive care units (ICUs) of the University Hospital of Basel

Exclusion Criteria:

• Patients with repetitive epileptic seizures not qualifying for SE or RSE
• Patients with documented refusal of the general in-house consent